Somayeh Shatizadeh Malekshahi

Dr. Somayeh Shatizadeh Malekshahi


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2010 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
SMSomayeh Shatizadeh Malekshahi
Somayeh Shatizadeh Malekshahi
TATalat Mokhtari Azad
Talat Mokhtari Azad
JYJila Yavarian
Jila Yavarian
SSShohreh Shahmahmoodi
Shohreh Shahmahmoodi
MNMaryam Naseri
Maryam Naseri
FRFarhad Rezaei
Farhad Rezaei
Viruses are the most common causes of respiratory tract infections in children. The implementation of rapid virology assays can identify the most common pathogens involved. This study was undertaken on Iranian children less than 6 years old with respiratory infection. A total of 202 specimens were tested for the presence of 9 respiratory viruses by developing 3 multiplex reverse transcription-polymerase chain reaction and 1 uniplex polymerase chain reaction assays. Viral pathogens were detected in 92 samples (45.5%) with 5.4% having dual infections. Overall, respiratory syncytial virus was the most frequently identified virus (16.8%), followed by adenovirus (14.4%), influenza A virus (4.9%), parainfluenza virus-3 (4.4%), parainfluenza virus-1 (2.9%), and both influenza B virus and hMPV (0.49). Respiratory tract infection is a frequent cause of pediatric morbidity and mortality and a common reason for admission in acute care hospitals and outpatients visits. Appropriate diagnostic testing is important for specific diagnosis at an early stage of the illness because of the similarity in clinical presentation of patients with different viral infections caused by several respiratory pathogens.

8 July 2023 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
MBMehdi Gholami Barzoki
Mehdi Gholami Barzoki
SMSomayeh Shatizadeh Malekshahi
Somayeh Shatizadeh Malekshahi
ZHZahra Heydarifard
Zahra Heydarifard
MMMohamad Javad Mahmodi
Mohamad Javad Mahmodi
HSHaleh Soltanghoraee
Haleh Soltanghoraee

25 December 2023 in Tropical Diseases, Travel Medicine and Vaccines
Verified
Journal Article
Open access
PDF file
AZArghavan Zebardast
Arghavan Zebardast
TLTayebeh Latifi
Tayebeh Latifi
NSNazanin-Zahra Shafiei-Jandaghi
Nazanin-Zahra Shafiei-Jandaghi
MBMehdi Gholami Barzoki
Mehdi Gholami Barzoki
SMSomayeh Shatizadeh Malekshahi
Somayeh Shatizadeh Malekshahi
Poxviruses are large and diversified viruses that cause an emerging zoonotic disease known as monkeypox (mpox). In the past, mpox predominated primarily in the rural rainforests of Central and West Africa. Recently, the exportation of mpoxv from Africa to other continents has been progressively reported. However, the lack of travel history to Africa in most of the currently reported cases in 2022 promotes the sign of changing epidemiology of this disease. Concerns over the geographic distribution and continued resurgence of mpox is growing. In this review, we addressed the geographic distribution, transmission, reasons for the resurgence of mpox, and vaccination. Although the precise cause of the resurgence in mpox cases is mostly unknown, several suggested factors are believed to be waning immunity, accumulation of unvaccinated people, ecological conditions, risk behaviors of men who have sex with men, and genetic evolution.

3 December 2020 in Microbiology and Immunology
Verified
Journal Article
Closed access
PDF file
MFMohammad Farahmand
Mohammad Farahmand
SMSomayeh Shatizadeh Malekshahi
Somayeh Shatizadeh Malekshahi
MJMohammad Reza Jabbari
Mohammad Reza Jabbari
MSMohammad Shayestehpour
Mohammad Shayestehpour

27 December 2021 in Congenital Anomalies
Verified
Journal Article
Closed access
PDF file
ZHZahra Heydarifard
Zahra Heydarifard
SZSevrin Zadheidar
Sevrin Zadheidar
JYJila Yavarian
Jila Yavarian
SMSomayeh Shatizadeh Malekshahi
Somayeh Shatizadeh Malekshahi
SKShirin Kalantari
Shirin Kalantari
NSNazanin Zahra Shafiei-Jandaghi
Nazanin Zahra Shafiei-Jandaghi

21 December 2020 in Biotechnology and Applied Biochemistry
Verified
Journal Article
Open access
PDF file
SMSomayeh Shatizadeh Malekshahi
Somayeh Shatizadeh Malekshahi
JYJila Yavarian
Jila Yavarian
NSNazanin Zahra Shafiei-Jandaghi
Nazanin Zahra Shafiei-Jandaghi
Coronaviruses recognize a variety of host receptors to infect many humans and animals. Newly emerged severe acute respiratory syndrome coronavirus2 (SARS‐CoV‐2) recognizes angiotensin‐converting enzyme 2 (ACE2) to gain entry into different cells. Interestingly, besides SARS‐CoV2, four other human coronaviruses (HCoVs) use three different ectopeptidases (ACE2, dipeptidyl peptidase 4, and aminopeptidase N) as receptors independent of their common peptidase activity. This issue has led to the important question “why do several HCoVs rely on peptidases as their receptors?.” In this paper, we discussed to answer this question. Mostly, it seems that the use of peptidases by HCoVs may be more related to their widespread presence on target cells and also viruses prefer to take advantage of molecules with relatively low affinity for their natural ligands through evolving a stronger binding affinity to the surface receptors for entry and endocytosis. Meanwhile evolutionary conservation of these receptors may allow HCoVs to switch between different host species. Finally, the choice of peptidases by HCoVs may reflect the “trial and error” nature of evolution. In conclusion, substantial efforts are needed to get a strong picture of this fascinating question and poorly explored area. Detailed understanding of the entry mechanisms offers opportunities for the development of refined strategies to stop viruses.